Table 3. Univariate analysis of age, sex, adjuvant chemo-radiotherapy, tumor stage, NLR, PLR and platelets in the study population.
| Patient characteristic | Overall survival | Disease-free survival | ||||
|---|---|---|---|---|---|---|
| HR | 95% CI | p-value | HR | 95% CI | p-value | |
| Agea (yrs): <60 >60 |
1.09 | 0.27-4.4 | 0.89 | 0.94 | 0.39-2.22 | 0.89 |
| Sex: female male |
2.03 | 0.46-8.29 | 0.36 | 1.26 | 0.5-3.12 | 0.63 |
| Adjuvant chemotherapy: no yes |
0.64 | 0.15-2.64 | 0.54 | 1.93 | 0.78-4.46 | 0.16 |
| Stage 3 4 |
2.89 | 0.22-169 | 0.29 | 1.42 | 0.28-8.31 | 0.63 |
| NLR <3.27 >3.27 |
4.75 | 1.4-33.83 | 0.017* | 4.38 | 2.49-19.24 | 0.0002* |
| Platelets <300 >300 |
1.12 | 0.28-4.54 | 0.87 | 1.64 | 0.69-3.9 | 0.26 |
| PLR <150 >150 |
2.05 | 0.47-8 | 0.36 | 2.41 | 0.97-5.39 | 0.059 |
NLR = neutrophil-to-lymphocyte ratio; PLR = platelet-to-lymphocyte ratio; HR = hazard ratio; 95% CI = 95% confidence interval; *p value lower than 0.05 set as the level of significance